IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms10856.html
   My bibliography  Save this article

AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B

Author

Listed:
  • M. Johanns

    (Université catholique de Louvain and de Duve Institute)

  • Y.-C. Lai

    (Université catholique de Louvain and de Duve Institute
    Present addresses: MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dundee, UK)

  • M.-F. Hsu

    (Université catholique de Louvain and de Duve Institute
    Present addresses: Graduate Institute of Sports Training, University of Taipei, No. 101, Sec. 2, Zhongcheng Road, Shilin Dist., 11153 Taipei City, Taiwan)

  • R. Jacobs

    (Université catholique de Louvain and de Duve Institute)

  • D. Vertommen

    (Université catholique de Louvain and de Duve Institute)

  • J. Van Sande

    (Faculté de Médecine, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB))

  • J. E. Dumont

    (Faculté de Médecine, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB))

  • A. Woods

    (Cellular Stress Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital)

  • D. Carling

    (Cellular Stress Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital)

  • L. Hue

    (Université catholique de Louvain and de Duve Institute)

  • B. Viollet

    (INSERM U1016, Institut Cochin
    CNRS UMR8104
    Université Paris Descartes, Sorbonne Paris Cité)

  • M Foretz

    (INSERM U1016, Institut Cochin
    CNRS UMR8104
    Université Paris Descartes, Sorbonne Paris Cité)

  • M H Rider

    (Université catholique de Louvain and de Duve Institute)

Abstract

Biguanides such as metformin have previously been shown to antagonize hepatic glucagon-stimulated cyclic AMP (cAMP) signalling independently of AMP-activated protein kinase (AMPK) via direct inhibition of adenylate cyclase by AMP. Here we show that incubation of hepatocytes with the small-molecule AMPK activator 991 decreases glucagon-stimulated cAMP accumulation, cAMP-dependent protein kinase (PKA) activity and downstream PKA target phosphorylation. Moreover, incubation of hepatocytes with 991 increases the Vmax of cyclic nucleotide phosphodiesterase 4B (PDE4B) without affecting intracellular adenine nucleotide concentrations. The effects of 991 to decrease glucagon-stimulated cAMP concentrations and activate PDE4B are lost in hepatocytes deleted for both catalytic subunits of AMPK. PDE4B is phosphorylated by AMPK at three sites, and by site-directed mutagenesis, Ser304 phosphorylation is important for activation. In conclusion, we provide a new mechanism by which AMPK antagonizes hepatic glucagon signalling via phosphorylation-induced PDE4B activation.

Suggested Citation

  • M. Johanns & Y.-C. Lai & M.-F. Hsu & R. Jacobs & D. Vertommen & J. Van Sande & J. E. Dumont & A. Woods & D. Carling & L. Hue & B. Viollet & M Foretz & M H Rider, 2016. "AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B," Nature Communications, Nature, vol. 7(1), pages 1-12, April.
    • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10856
    DOI: 10.1038/ncomms10856
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms10856
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms10856?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10856. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.